This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-surprise: Archive
AvePoint, Inc. (AVPT) Meets Q2 Earnings Estimates
by Zacks Equity Research
AvePoint (AVPT) delivered earnings and revenue surprises of 0.00% and +5.72%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
AVPTPositive Net Change EGANPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Metallus (MTUS) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Metallus (MTUS) delivered earnings and revenue surprises of +25.00% and +8.83%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MTUSNegative Net Change GRWGPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Onto Innovation (ONTO) Q2 Earnings Lag Estimates
by Zacks Equity Research
Onto Innovation (ONTO) delivered earnings and revenue surprises of -1.57% and +1.54%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ONTONegative Net Change TLSPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Progyny (PGNY) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Progyny (PGNY) delivered earnings and revenue surprises of +9.09% and +3.22%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PGNYNegative Net Change CODXNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Century Aluminum (CENX) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Century (CENX) delivered earnings and revenue surprises of -114.71% and -3.47%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CENXNegative Net Change LAKEPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
HA Sustainable Infrastructure Capital (HASI) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
HA Sustainable Infrastructure Capital (HASI) delivered earnings and revenue surprises of -3.23% and -75.50%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
HASIPositive Net Change BTCSPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
HCI Group (HCI) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
HCI Group (HCI) delivered earnings and revenue surprises of +15.88% and +1.57%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
HCIPositive Net Change AFCGNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Main Street Capital (MAIN) Q2 Earnings Meet Estimates
by Zacks Equity Research
Main Street Capital (MAIN) delivered earnings and revenue surprises of 0.00% and +4.92%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MAINPositive Net Change ESNTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
ABCELLERA BIOLG (ABCL) delivered earnings and revenue surprises of +29.41% and +146.95%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ABCLNegative Net Change XAIRNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Wheaton Precious Metals Corp. (WPM) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Wheaton Precious Metals (WPM) delivered earnings and revenue surprises of +8.62% and +7.58%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
WPMPositive Net Change AMRPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Evolent Health (EVH) Reports Q2 Loss, Misses Revenue Estimates
by Zacks Equity Research
Evolent Health (EVH) delivered earnings and revenue surprises of -211.11% and -2.86%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
EVHNegative Net Change VEEVNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Kura Oncology (KURA) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Kura Oncology (KURA) delivered earnings and revenue surprises of -600.00% and -89.23%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
KURANegative Net Change ROIVNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Natera (NTRA) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Natera (NTRA) delivered earnings and revenue surprises of -23.33% and +15.66%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
NTRAPositive Net Change AUNAPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
RxSight, Inc. (RXST) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
RxSight (RXST) delivered earnings and revenue surprises of +20.00% and +0.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
RXSTNegative Net Change CLPTNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Alector (ALEC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Alector (ALEC) delivered earnings and revenue surprises of +33.33% and +177.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ALECPositive Net Change IVVDPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
QuinStreet (QNST) Q4 Earnings Lag Estimates
by Zacks Equity Research
QuinStreet (QNST) delivered earnings and revenue surprises of -3.85% and +1.59%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
QNSTPositive Net Change INTUNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
CarGurus (CARG) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
CarGurus (CARG) delivered earnings and revenue surprises of +5.56% and +0.57%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CARGNegative Net Change GCONegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Eventbrite (EB) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Eventbrite (EB) delivered earnings and revenue surprises of +75.00% and +1.12%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
EBNegative Net Change PATHNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Consolidated Edison (ED) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Con Ed (ED) delivered earnings and revenue surprises of +1.52% and +6.17%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
EDPositive Net Change GWRSNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Eton Pharmaceuticals (ETON) delivered earnings and revenue surprises of -900.00% and +13.24%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ETONPositive Net Change ADCTNo Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Abacus Life, Inc. (ABL) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Abacus Life, Inc. (ABL) delivered earnings and revenue surprises of +37.50% and +33.05%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
ABLNegative Net Change CMPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Sweetgreen, Inc. (SG) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Sweetgreen (SG) delivered earnings and revenue surprises of -66.67% and -3.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SGNegative Net Change RRGBNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Treace Medical Concepts (TMCI) Reports Q2 Loss, Beats Revenue Estimates
by Zacks Equity Research
Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of +3.45% and +0.79%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
TMCINegative Net Change HYPRPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Globus Medical (GMED) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Globus Medical (GMED) delivered earnings and revenue surprises of +13.16% and +0.49%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
GMEDNegative Net Change ELMDPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Identiv, Inc. (INVE) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Identiv (INVE) delivered earnings and revenue surprises of +16.13% and -1.18%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
INVEPositive Net Change PLUGNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank